Cambridge Healthtech Institute’s 2nd Annual

Extracellular Vesicles

Biomarkers, Drug Delivery and Therapeutics

June 17, 2019


A rapid expansion of research into Extracellular Vesicles is yielding numerous healthcare industry applications including their use as biomarkers, in diagnostics, as therapeutic delivery vectors and as therapeutics themselves. Yet many challenges are yet to be overcome, including a lack of standardization for sample preparation and isolation techniques, too little regulatory guidance, scale-up and GMP manufacturing difficulties and not enough clinical evidence. At Cambridge Healthtech Institute’s 2nd Annual Extracellular Vesicles Symposium, discover the latest findings of leading researchers from industry and academia who are endeavouring to realize their true importance. Receive expert opinion from industry leaders on microvesicles and exosomes in biomarkers, diagnostics and precision medicine, therapeutics and drug delivery, without being limited to any one specific therapeutic area.

EXTRACELLULAR VESICLES IN BIOMARKERS, DIAGNOSTICS AND PRECISION MEDICINE

KEYNOTE PRESENTATION: Exosome-Based Liquid Biopsies for Cancer and Beyond<

Johan Skog, PhD, CSO, Exosome Diagnostics

Biochemical Architecture and Morphological Release Pathways of the Human Platelet Extracellular Vesicles<

Silvia De Paoli, PhD, Senior Scientist, Center for Biologics Evaluation and Research, Food and Drug Administration

THERAPEUTICS AND DRUG DELIVERY WITH EXTRACELLULAR VESICLES

Deconstructing Regenerative Medicine: From Cells to Exosomes and Defined Factors<

Eduardo Marban, PhD, Director of the Cedars-Sinai Heart Institute, Cedars-Sinai Medical Center, Founder, Capricor Therapeutics

Extracellular Vesicles in Regenerative Medicine<

Maria Mirotsou, PhD, Senior Director of Research, Astellas Institute of Regenerative Medicine (AIRM)

Development of Exosome-Based Protein Replacement Therapies<

Per Lundin, PhD, Co-Founder and COO, Evox Therapeutics

Cellular Sources of Extracellular Vesicles for Induced Tissue Regeneration

Dana Larocca, PhD, Vice President, Research and Development, AgeX Therapeutics


For more details on the conference, please contact:
Joel Hornby
Conference Director
Cambridge Healthtech Institute
Phone: 781-247-1816
Email: jhornby@healthtech.com

For partnering and sponsorship information, please contact:


Companies A-K
Rod Eymael
Business Development Manager
Cambridge Healthtech Institute
Phone: 781-247-6286
Email: reymael@healthtech.com

Companies L-Z
Joseph Vacca, M.S.
Director, Business Development
Cambridge Healthtech Institute
Phone: 781-972-5431
Email: jvacca@healthtech.com